Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · IEX Real-Time Price · USD
20.24
-0.68 (-3.25%)
At close: Jul 19, 2024, 4:00 PM
20.27
+0.03 (0.15%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Jasper Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 70.75, with a low estimate of 40 and a high estimate of 90. The average target predicts an increase of 249.56% from the current stock price of 20.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for JSPR stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 3 |
| Buy | 4 | 6 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 7 | 8 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $90 | Strong Buy | Initiates | $90 | +344.66% | Jul 8, 2024 |
| Stifel | Stifel | Strong Buy Initiates $86 | Strong Buy | Initiates | $86 | +324.90% | Jun 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +221.15% | May 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +221.15% | May 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
8.98M
EPS This Year
-4.42
from -6.18
EPS Next Year
-4.22
from -4.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 46.2M | 10.5M | 67.9M | 190.5M |
| Avg | n/a | 9.0M | 2.6M | 14.1M | 77.4M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 17.0% | 2,530.1% | 1,249.8% |
| Avg | - | - | -71.2% | 446.3% | 448.3% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.05 | -2.56 | -3.95 | -2.88 | 2.34 |
| Avg | -4.42 | -4.22 | -5.20 | -4.48 | -3.16 |
| Low | -4.72 | -4.98 | -6.01 | -6.15 | -6.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.